Grifols, S.A. (GRFS)
Healthcare
- Fundamental
- 3
- Sentiment
- 3
- Technical
- 2
Do Nothing: 9 core indicators failed to load (ema9, ema21, wma9, wma21, dema14, tema14, stdDev20, rsi14, adx14); technical read is unreliable and no bullish entry can be scored.
Company overview
Grifols, S.A., headquartered in Barcelona, Spain, develops, manufactures, and distributes therapeutic products, primarily derived from human plasma. The company operates through divisions focused on plasma-derived medicines, hospital supplies, diagnostic products, and biological materials for research and manufacturing. Grifols serves healthcare organizations, wholesalers, and national health systems globally.
Fundamental
fairImproving profitability and reduced maturity pressure, but high leverage and plasma-supply risks remain.
Mixed: improving profitability and refinancing reduced near-term maturity pressure, but leverage remains elevated (~4.2x net debt/EBITDA) and the business is exposed to plasma-supply and regulatory risks; valuation and DCF metrics were unavailable in this run.
Sentiment
fairPositive earnings coverage is offset by ongoing regulatory scrutiny, creating conflicting signals.
Last ~14d media coverage is sparse but positive around the 2026-07-29 Q2 earnings call (announced) and reads more bullish than the May–early July baseline. Ongoing Health Canada scrutiny of Canadian plasma-donation centers is a bearish unresolved overhang, creating conflicting signals that cap the qualitativeScore at 3.
Technical
weakKey momentum indicators failed to load, preventing confirmation of a reliable long setup.
Price is above SMA20 (7.61) and SMA50 (7.54) and roughly above daily VWAP (~8.05), but still below SMA200 (8.42). Liquidity is acceptable (avgDollarVolume20 5914715.65; recent 3-session regular average about 3600637.90) and overnight gaps are modest (max 0.89%), yet the core momentum/trend stack failed to load—EMA9, EMA21, RSI14, ADX14, WMA9, WMA21, DEMA14, TEMA14, StdDev20, and the EMA-derived MACD suite—so the read is degraded and capped at 2.
You’re looking at 2026-08-04 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.